Combined, these two products made up 45% of the top line in the third quarter, so it's a legitimate worry. Still, BMS has ...

ALX Oncology Holdings, a Californian immuno-oncology company, has announced the appointment of Alan Sandler as chief medical ...

UBS analyst Trung Huynh maintained a Hold rating on Pfizer (PFE – Research Report) today and set a price target of $31.00. The ...

Vislink Technologies, Inc. ( NASDAQ: VISL) Q3 2024 Earnings Conference Call November 14, 2024 8:30 AM ET Mickey Miller - Chief Executive Officer Mike Bond - Chief Financial Officer ...

Combination Would Create a Global Innovative Services Company with a Unique Set of Differentiated Technologies, a Deep Pipeline, ...

BMS’ CC-97540 and Cabaletta Bio’s CABA-201 showed significant ... Life Sciences service that brings together a daily update ...

The Rimmer 911 was a 1991 Porsche 964 911 redefined by Everrati to a 500-hp electric. It’s sporting the company’s 964 ...

Leerink Partners analyst David Risinger has reiterated their bullish stance on CNTA stock, giving a Buy rating yesterday. David Risinger has ...

Roughly a year ago, Gilead Sciences revealed that it was laying off about 7% of Kite Pharma’s workforce in a bid to refresh ...

In FY26, it aims to create a strong presence in at least 1-2 major markets to have a sizable export business. However, as the ...